First Trust Advisors
TFFP

First Trust Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

First Trust Advisors’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,494
Closed -$359K – 2661
2021
Q2 		$359K Buy
1,494
+255
+21% +$69.9K ﹤0.01% 2345
2021
Q1 		$420K Buy
1,239
+99
+9% +$40.3K ﹤0.01% 2258
2020
Q4 		$408K Sell
1,140
-50
-4% -$19.3K ﹤0.01% 2163
2020
Q3 		$549K Buy
+1,190
New +$336K ﹤0.01% 2008

Other funds holding TFFP

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

First Trust Advisors's TFFP Position: Q3 2021 in Review

First Trust Advisors sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2021, closing a stake of 1,494 shares — an estimated $359K sold.

First Trust Advisors first reported a position in TFFP in Q3 2020 and held it in 4 quarters. The position peaked at $549K in Q3 2020. 54 funds tracked by Wall St. Rank hold TFFP as of Q3 2021.

  • First Trust Advisors reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • First Trust Advisors sold 1,494 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $359K.
  • First Trust Advisors first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • First Trust Advisors's TFF Pharmaceuticals, Inc. Common Stock position peaked at $549K in Q3 2020.
  • 54 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.